Holen Sie sich die Stockscreener-App
1.55
0.98%
0.015
Handel nachbörslich:
1.56
0.01
+0.65%
Schlusskurs vom Vortag:
$1.535
Offen:
$1.53
24-Stunden-Volumen:
29,326
Relative Volume:
0.11
Marktkapitalisierung:
$66.59M
Einnahmen:
$51.13M
Nettoeinkommen (Verlust:
$-93.80M
KGV:
-0.6951
EPS:
-2.23
Netto-Cashflow:
$-129.10M
1W Leistung:
-0.64%
1M Leistung:
+3.33%
6M Leistung:
+20.16%
1J Leistung:
-48.50%
1-Tages-Spanne:
$1.53
$1.58
1-Wochen-Bereich:
$1.52
$1.59
52-Wochen-Spanne:
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
Firmenname
Repare Therapeutics Inc
Sektor
Branche
Telefon
(857) 412-7018
Adresse
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Vergleichen Sie RPTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
1.55 | 66.16M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.46 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.16 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.55 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.73 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.97 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-09 | Hochstufung | Stifel | Hold → Buy |
| 2023-02-03 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-06 | Eingeleitet | CapitalOne | Overweight |
| 2022-04-12 | Herabstufung | Stifel | Buy → Hold |
| 2022-03-17 | Fortgesetzt | Goldman | Buy |
| 2021-09-23 | Eingeleitet | Stifel | Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-03-01 | Eingeleitet | Berenberg | Buy |
| 2020-10-28 | Eingeleitet | Northland Capital | Outperform |
| 2020-07-14 | Eingeleitet | Cowen | Outperform |
| 2020-07-14 | Eingeleitet | Goldman | Neutral |
| 2020-07-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Repare Therapeutics Inc Aktie (RPTX) Neueste Nachrichten
Bollinger Bands Show Potential Breakout in Repare Therapeutics Inc.Market Sentiment Review & Community Shared Stock Ideas - 선데이타임즈
What earnings revisions data tells us about Repare Therapeutics Inc.July 2025 PreEarnings & Reliable Intraday Trade Alerts - Newser
What MACD and RSI say about Repare Therapeutics Inc.July 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Using RSI to spot recovery in Repare Therapeutics Inc.Quarterly Profit Report & Free Safe Capital Growth Stock Tips - Newser
Analyzing drawdowns of Repare Therapeutics Inc. with statistical toolsWeekly Stock Recap & Consistent Growth Equity Picks - Newser
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates - MSN
Institutional scanner results for Repare Therapeutics Inc.2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
Predicting Repare Therapeutics Inc. trend using moving averagesMarket Volume Report & Detailed Earnings Play Strategies - Newser
Will Repare Therapeutics Inc. benefit from macro trendsPortfolio Update Report & Safe Capital Investment Plans - Newser
Backtesting results for Repare Therapeutics Inc. trading strategiesTrade Risk Assessment & Proven Capital Preservation Methods - Newser
Automated trading signals detected on Repare Therapeutics Inc.Market Trend Report & Weekly Stock Breakout Alerts - Newser
Repare Therapeutics Inc. stock trendline breakdownJuly 2025 Volume & Reliable Price Breakout Alerts - Newser
Is Repare Therapeutics Inc. still worth holding after the dipWeekly Trend Summary & Community Consensus Stock Picks - Newser
Repare Therapeutics (NASDAQ:RPTX) Announces Earnings Results - MarketBeat
Will Repare Therapeutics Inc. Bounce From 52 Week Low2025 Big Picture & Weekly Market Pulse Alerts - beatles.ru
Repare Therapeutics (NASDAQ:RPTX) Upgraded to Hold at Wall Street Zen - MarketBeat
Candlestick Reversal Detected on Repare Therapeutics Inc.’s ChartScalable Portfolio Growth Suggestions Released - 선데이타임즈
Using portfolio simulators with Repare Therapeutics Inc. includedSafe Investment Ideas with Growth Upside - Newser
Repare Therapeutics (NASDAQ:RPTX) Raised to Hold at Wall Street Zen - Defense World
Is Repare Therapeutics Inc. forming a reversal patternFree Market Surge Signal for Swing Traders - Newser
Is Repare Therapeutics Inc. Stock a Good Fit for Conservative InvestorsSafe Momentum Strategy With Trend Analysis - Newser
Repare Therapeutics Q2 2025 Earnings: EPS Beats Estimates, Revenue Surpasses Expectations - AInvest
Repare Therapeutics Inc (RPTX) Q2 2025 Earnings: EPS of -$0.39 B - GuruFocus
Analyzing recovery setups for Repare Therapeutics Inc. investorsFree Smart Trend Trading with Weekly Signals - Newser
Repare Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Repare Therapeutics Reports Q2 2025 Results and Strategic Moves - TipRanks
Repare Therapeutics Reports Q2 Earnings: Strategic Moves and Upcoming Data Releases - AInvest
Repare Therapeutics Announces Licensing Deal and Strategic Updates - The Globe and Mail
Repare 2025 Q2 Earnings Strong Improvement as Net Loss Narrows 51.8% - AInvest
Repare Therapeutics Cuts Losses And Snags New Licensing Deals - Finimize
Repare Therapeutics Narrows Losses And Seeks New Paths Forward - Finimize
Repare (RPTX) Q2 Loss Narrows 52% - AOL.com
Repare Therapeutics' Strategic Shift and Milestone-Driven Outlook - AInvest
Repare Therapeutics reports Q2 EPS (39c) vs. (82c) last year - TipRanks
Repare Therapeutics Inc. SEC 10-Q Report - TradingView
Repare Therapeutics Q2 net loss narrows to $16.7 mln - MarketScreener
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results | RPTX Stock News - GuruFocus
Finanzdaten der Repare Therapeutics Inc-Aktie (RPTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Repare Therapeutics Inc-Aktie (RPTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER |
Mar 12 '25 |
Sale |
1.14 |
5,611 |
6,397 |
80,297 |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER |
Mar 12 '25 |
Sale |
1.14 |
6,884 |
7,848 |
54,786 |
| Segal Lloyd Mitchell | PRESIDENT AND CEO |
Mar 12 '25 |
Sale |
1.14 |
21,179 |
24,144 |
124,394 |
1.55%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):